| ¿µ¹® | flow | ÇÑ±Û | È帧, À¯·® |
|---|---|---|---|
| ¼³¸í | ¾×ü ¶Ç´Â ±âüÀÇ °¢ ºÎºÐÀÌ ½Ã°£°ú ÇÔ²² ¿¬¼ÓÀûÀ¸·Î ±× À§Ä¡¸¦ À̵¿ÇÏ´Â Çö»ó. ±× ¾ç»óÀº º¹ÀâÇÏÁö¸¸ °¢ Á¡¿¡¼ÀÇ È帧ÀÇ ¹æÇâÀÌ ±× Á¡¿¡¼ÀÇ Á¢¼± ¹æÇâ°ú ÀÏÄ¡Çϵµ·Ï ¼±À» ±×À¸¸é È帧ÀÇ ¸ð¾çÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ°Ô µÈ´Ù. |
||
| ¿µ¹® | blood clotting, blood coagulation | ÇÑ±Û | Ç÷¾×ÀÀ°í |
|---|---|---|---|
| ¼³¸í | »ç¶÷ÀÇ ¸ö¿¡ »óó°¡ ³ª¼ ÃâÇ÷ÀÌ ÀÖÀ» °æ¿ì¿¡ À̰ÍÀ» ¸·°í ÇǸ¦ ´õÀÌ»ó ³ªÁö ¾Ê°Ô ÇÏ´Â °ÍÀ» ÁöÇ÷À̶ó°í ÇÑ´Ù. ÁöÇ÷ÀÇ °úÁ¤¿¡´Â Å©°Ô µÎ °¡Áö ´Ü°è°¡ ÀÖ´Ù. ù¹øÂ° ´Ü°è´Â Ç÷¼ÒÆÇµéÀÌ »óó°¡ ³ª¼ ¼Õ»óµÈ Ç÷°üÀÇ ºÎÀ§¸¦ ¸·´Â °ÍÀÌ´Ù. ÀÌ·¸°Ô ÇÏ¸é ¿ì¼± Ç÷°üÀÇ ¼Õ»óºÎÀ§·Î ºÎÅÍ Çǰ¡ ³ª¿À´Â °ÍÀ» ¸·À» ¼ö°¡ ÀÖ´Ù. ´ÙÀ½ÀÇ ´Ü°è´Â »óó¸¦ ¸·°í ÀÖ´Â Ç÷¼ÒÆÇÀ§¿¡ ¿©·¯ °¡Áö ¹°ÁúµéÀÌ ÀÛ¿ëÇØ¼ ´õ¿í ´Ü´ÜÇÏ°Ô ÇÏ¿© »óó°¡ ³ Ç÷°ü¿¡¼ Çǰ¡ »õ´Â °ÍÀ» ¿µ±¸È÷ ¸·´Â °ÍÀÌ´Ù. ½±°Ô ¸»Çϸé Ç÷¼ÒÆÇÀº º®µ¹¿¡ ÇØ´çÇÏ´Â °ÍÀÌ°í µÎ¹øÂ° °úÁ¤¿¡ Âü¿©ÇÏ´Â ¹°ÁúµéÀº ½Ã¸àÆ®¿¡ ÇØ´çÇÏ´Â °ÍÀÌ´Ù. ÀÌ µÎ °úÁ¤ÀÌ ¿ÏÀüÇÒ °æ¿ì¿¡ ÁöÇ÷ÀÌ ¼øÁ¶·Ó°Ô ÀϾÙ. Ç÷¾×ÀÀ°í¶õ µÎ¹øÂ° ´Ü°è¸¦ ÁöĪÇÏ´Â ¸»·Î½á ¸Å¿ì º¹ÀâÇÑ ´Ü°è¸¦ °ÅÄ¡´Â ¹ÝÀÀÀ¸·Î ¸¶Áö¸· ´Ü°è´Â ¼¶À¯¼Ò¶ó´Â ¹°ÁúÀÌ ¸¸µé¾îÁ®¼ ÀÌ ¹°ÁúÀÌ Ç÷¼ÒÆÇ°ú ±× ¿ÜÀÇ ¼¼Æ÷¸¦ ´Ü´ÜÇÏ°Ô °íÁ¤½ÃÄÑ Çǰ¡ »óó³ Ç÷°üÀ¸·Î »õ´Â °ÍÀ» ¸·´Â´Ù. À̰ÍÀ» °¡Àå °£´ÜÈ÷ ¼³¸íÇÏÀÚ¸é Å©°Ô ´ÙÀ½°ú °°Àº 3°¡Áö ´Ü°è·Î ÀÌ·ç¾îÁø´Ù. ù¹øÂ° ´Ü°è´Â Ç÷°ü¼Õ»ó¿¡ ÀÇÇØ¼ ÇÁ·ÎÆ®·Òºó Ȱ¼ºÁ¦¶ó´Â °ÍÀÌ ¸¸µé¾îÁö´Â ´Ü°èÀÌ´Ù. µÎ¹øÂ° ´Ü°è´Â ÀÌ ÇÁ·ÎÆ®·Òºó Ȱ¼ºÁ¦¶ó´Â ¹°Áú¿¡ ÀÇÇØ¼ Ç÷¾×¼Ó¿¡ ÀÖ´Â ÇÁ·ÎÆ®·ÒºóÀ̶ó´Â ¹°ÁúÀÌ Æ®·ÒºóÀ̶ó´Â ¹°Áú·Î ¹Ù²î´Â ´Ü°èÀÌ´Ù. ¼¼¹øÂ° ´Ü°è´Â Æ®·ÒºóÀ̶ó´Â ¹°Áú¿¡ ÀÇÇØ¼ ¼¶À¯¼Ò¿øÀ̶ó´Â ¹°ÁúÀÌ ¼¶À¯¼ÒÀ¸·Î ¹Ù²î´Â ´Ü°èÀÌ´Ù. |
||
| ¿µ¹® | percutaneous transluminal coronary angioplasty | ÇÑ±Û | °æÇǰæÇ÷°ü½ÉÀ嵿¸ÆÈ®Àå¼ú=PTCA |
|---|---|---|---|
| ¼³¸í | ¼ö¼úÀ» ÇÏÁö ¾Ê°í ÀûÀº ÇÕº´ÁõÀ¸·Î ½ÉÀ嵿¸ÆÀÇ ¹Ý°æÀ» ´ÃÀÏ ¼ö ÀÖ´Â ¹æ¹ý. ½ÉÀ嵿¸Æ(Coronary artery)À̶õ, ½ÉÀåÀÇ Ç÷¾×À» °ø±ÞÇÏ´Â ½ÉÀå¿¡ Á¸ÀçÇÏ´Â µ¿¸ÆÀ» ¸»ÇÑ´Ù. ÀÌ·± ½ÉÀ嵿¸ÆÀÌ º´ÀûÀÎ »óÅ·Π±× ³»°ÀÌ Á¼¾ÆÁö°Ô µÇ¸é, ½ÉÀåÀÇ ÇãÇ÷ÀÌ ¹ß»ýÇÏ¿© À̸¥¹Ù Çù½ÉÁõÀ» À¯¹ßÇÏ°Ô µÇ°í, ½ÉÇÏ¸é ½ÉÀåÀÇ °æ»öÁõÀÌ ¹ß»ýÇÏ¸ç °á±¹Àº ȯÀÚÀÇ »ý¸íÀ» ¾Ñ¾Æ°£´Ù. µû¶ó¼ ÀÌ·± Á¼¾ÆÁø ½ÉÀ嵿¸ÆÀÌ ÀÖÀ¸¸é ³ÐÇôÁÖ¾î¾ß ÇÑ´Ù. ½ÉÀ嵿¸ÆÀ» ³ÐÇôÁÖ´Â ¹æ¹ýÀ¸·Î, Ç÷Àü¿¡ ÀÇÇÑ °æ¿ì ¾à¹°À» ÀÌ¿ëÇÏ¿© ¿ëÇØ½Ãų ¼öµµ ÀÖÀ¸³ª, ÀÌ¹Ì ¿À·¡µÈ °æ¿ì´Â ¾à¹°·Î½á Ä¡·á´Â ºÒ°¡´ÉÇÏ´Ù. À̶§ ¼ö¼úÀû ¹æ¹ý°ú ÀÌ °æÇÇÀû°æÇ÷°ü½ÉÀ嵿¸ÆÈ®Àå¼úÀ» ½ÃÇàÇÑ´Ù. ¼ö¼úÀû ¹æ¹ýÀº Á÷Á¢ °¡½¿À» ¿°í ½ÉÀåÀÇ Á¼¾ÆÁø Ç÷°üÀ» Á¦°ÅÇÏ°í ´Ù¸¥ Ç÷°üÀ¸·Î ´ëÄ¡ÇÏ´Â µ¿¸ÆÀ̽ļúÀ̸ç, °æÇÇÀû°æÇ÷°ü½ÉÀ嵿¸ÆÈ®Àå¼úÀº ÇǺθ¦ ÅëÇÏ¿© (°æÇÇÀû)ÇǺιØÀÇ µ¿¸ÆÀ» ã¾Æ, µ¿¸Æ¼ÓÀ» Áö³ª¼ (°æÇ÷°ü)½ÉÀ嵿¸Æ¿¡ À̸£·¯, µ¿¸ÆÀ» È®ÀåÇÏ´Â ¹æ¹ýÀ» ¸»ÇÑ´Ù. |
||
| ¿µ¹® | coronary artery bypass surgery | ÇÑ±Û | ½ÉÀ嵿¸Æ µÎ¸§±æ¼ö¼ú, ½ÉÀ嵿¸Æ¿ìȸ·Î ¼ö¼ú |
|---|---|---|---|
| ¼³¸í | ½ÉÀ嵿¸ÆÀ̶õ ½ÉÀå¿¡ Ç÷¾×À» °ø±ÞÇÏ´Â µ¿¸ÆÀ» À̸£´Â ¸»·Î ½ÉÀ忪½Ã ±ÙÀ°ÀÌ¾î¼ Ç÷¾×À» °ø±Þ¹Þ¾Æ¾ß ¼öÃàÀ» ÇÒ ¼ö°¡ ÀÖ´Ù. ½ÉÀ嵿¸ÆÀÌ Á¼¾ÆÁú °æ¿ì¿¡´Â ½ÉÀå¿¡ Ç÷¾×ÀÇ °ø±ÞÀÌ ¾ø¾îÁ®¼ ½ÉÀ嵿¸Æº´À̶ó´Â º´À» ÀÏÀ¸Å²´Ù. ½ÉÀ嵿¸Æ µÎ¸§±æ¼ö¼ú(coronary artery bypass surgery)À̶õ ½ÉÀ嵿¸Æº´¿¡¼ Á¼¾ÆÁø Ç÷°üºÎÀ§ ¶§¹®¿¡ »ý±â´Â Ç÷¾×°ø±ÞÀÌ Àû¾îÁø ºÎÀ§¿¡ Ç÷¾×°ø±ÞÀ» ¿øÈ°ÇÏ°Ô ÇØÁÖ´Â ¼ö¼ú¹æ¹ýÀ¸·Î ´Ù¸¥ ºÎÀ§ÀÇ Ç÷°üÀ̳ª ÀΰøÀûÀÎ ¹°ÁúÀ» ÀÌ¿ëÇØ¼ Á¼¾ÆÁø Ç÷°üºÎÀ§ÀÇ ¾Õ, µÚ¸¦ ¿¬°áÇÏ¿© Ç÷·ù°¡ Á¼¾ÆÁø ºÎºÐÀ» Áö³ªÁö ¾Ê°í »õ·Î ¿¬°áµÈ ºÎºÐÀ» Áö³ª°Ô ÇÏ¿© Ç÷·ù¸¦ Áõ°¡½ÃŰ´Â ¹æ¹ýÀÌ´Ù. |
||
| ¿µ¹® | coronary artery disease | ÇÑ±Û | ½ÉÀ嵿¸Æº´ |
|---|---|---|---|
| ¼³¸í | ½ÉÀ嵿¸ÆÀ̶õ ½ÉÀå¿¡ Ç÷¾×À» °ø±ÞÇÏ´Â µ¿¸ÆÀ» ¸»ÇÑ´Ù. ½ÉÀåµµ ´Ù¸¥ ±ÙÀ°°ú ¸¶Âù°¡Áö·Î Ç÷¾×À» °ø±Þ¹Þ¾Æ¾ß ¼öÃàÀ» ÇÒ ¼ö°¡ ÀÖ´Â ±â°üÀ¸·Î ½ÉÀåÀÇ Ç÷¾×À» °ø±ÞÇÏ´Â µ¿¸ÆÀ» ½ÉÀ嵿¸ÆÀ̶ó°í ÇÑ´Ù. ½ÉÀ嵿¸Æº´À̶õ ½ÉÀ嵿¸ÆÀÇ ³»°æÀÌ Á¼¾ÆÁ®¼ »ý±â´Â ÁúȯÀ¸·Î ÇãÇ÷½ÉÀ庴(ischemic heart disease)À̶ó°íµµ ºÒ¸°´Ù. °ü»óµ¿¸ÆÀÌ Á¼¾ÆÁú °æ¿ì¿¡´Â ½ÉÀåÀ¸·Î °¡´Â Ç÷¾×ÀÇ ¾çÀÌ Àû¾îÁ®¼ ½ÉÀå¿¡ ÃæºÐÇÑ Ç÷¾×ÀÌ °ø±ÞÀÌ µÇÁö ¸øÇϹǷΠ¿©·¯ °¡Áö º´ÀûÀÎ Çö»óÀÌ »ý±ä´Ù. ½ÉÀ嵿¸ÆÀÌ Á¼¾ÆÁö´Â µ¥¿¡´Â ¿©·¯ °¡Áö ¿øÀÎÀÌ ÀÖÀ» ¼ö°¡ ÀÖÀ¸³ª ÁÖ·Î ½ÉÀ嵿¸ÆÀÇ µ¿¸Æ°æÈÁõ¿¡ ÀÇÇÑ´Ù. µ¿¸Æ°æÈÁõÀ̶õ µ¿¸ÆÀÇ ³»Ãþ¿¡ Áö¹æ°ú ÄÝ·¹½ºÅ×·Ñ·Î ÀÌ·ç¾îÁø Á×Á¾(atheroma)°¡ »ý±â´Â ÁúȯÀ¸·Î Á×Á¾ÀÌ »ý±ä µ¿¸ÆÀº Á×Á¾ÀÌ Ç÷°üÀÇ ³»ºÎ·Î µ¹ÃâÇÏ°Ô µÇ¾î¼ Ç÷°üÀÇ ³»°æÀÌ ÀÛ¾ÆÁö°Ô µÈ´Ù. ½ÉÀ嵿¸Æº´Àº ±× Á¤µµ¿¡ µû¶ó¼ Çù½ÉÁõ(angina pectoris)¿Í ½É±Ù°æ»öÁõ(myocardial infarction)À¸·Î ³ª´«´Ù. Çù½ÉÁõÀº ½ÉÀ嵿¸ÆÀÇ ºÎºÐÀû Æó¼â¿¡ ÀÇÇØ¼ Æò»ó½Ã¿¡´Â Áõ»óÀÌ ¾øÁö¸¸ ½ÉÀåÀÌ ¸¹Àº Ȱµ¿À» ÇÒ °æ¿ì¿¡ ½ÉÀå¿¡ Çǰ¡ ÃæºÐÇÑ ¸¸Å °ø±ÞÀÌ µÇÁö ¾Ê¾Æ¼ »ý±â´Â Áúº´À¸·Î Æò»ó½Ã¿¡ ½¯ °æ¿ì¿¡´Â ¾Æ¹« Áõ»óÀÌ ¾øÁö¸¸ ¿îµ¿À̳ª °ú½Ä µîÀÇ ¿øÀÎÀ¸·Î ½ÉÀåÀÌ ¸¹Àº ¿îµ¿À» ÇÒ °æ¿ì¿¡ ½ÉÀå¿¡ °ø±ÞµÇ´Â Ç÷¾×ÀÇ ¾çÀÌ ¸ðÀÚ¶ó¼ Áõ»ó(´ë°³ °¡½¿ºÎÀ§¿¡ Áã¾îÂ¥´Â µíÇÑ ÅëÁõ)ÀÌ »ý±ä´Ù. ½É±Ù°æ»öÁõÀ̶õ ½ÉÀ嵿¸ÆÀÇ ¿ÏÀüÆó¼â¿¡ ÀÇÇØ¼ ½ÉÀåÀÇ ±ÙÀ°ÀÌ Ç÷¾×À» ÀüÇô °ø±Þ¹ÞÁö ¸øÇؼ ½ÉÀåÀÇ ±ÙÀ°ÀÌ ½â´Â °æ¿ì¸¦ ¸»ÇÑ´Ù. |
||
| CBF | capillary blood flow; cerebral blood flow; ciliary beat frequency; coronary blood flow; cortical blo... |
|---|---|
| HBF | hand blood flow; hemispheric blood flow; hemoglobinuric bilious fever; hepatic blood flow; hypothala... |
| ECG | Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ = EKG 1. Conducting System Structu... |
| EHBF | estimated hepatic blood flow; exercise hyperemia blood flow; extrahepatic blood flow |
| MBF | medullary blood flow; muscle blood flow; myocardial blood flow |
| CBF | Coronary blood flow |
|---|---|
| CBFV | Coronary blood flow velocity |
| CSBF | Coronary sinus blood flow |
| CSF | Coronary sinus blood flow |
| CF | Coronary flow |
| blood flow velocity | A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. (12 Dec 1998) |
|---|---|
| renal blood flow, effective | The amount of blood flowing to the parts of the kidney that are involved with the production of constituents of urine. It is that portion of the total renal blood flow that perfuses functional renal tissue (e.g., the glomeruli). It should be differentiated from renal plasma flow, effective which is based on the amount of plasma rather than on total renal blood. (12 Dec 1998) |
| effective renal blood flow | The amount of blood flowing to the parts of the kidney that are involved with production of constituents of urine. (05 Mar 2000) |
| average flow rate | <physiology> The flow rate determined by dividing the total volume passed in a time period divided by the time period, usually quoted in mls per minute. (05 Mar 2000) |
| Bingham flow | The flow characteristics exhibited by a Bingham plastic. (05 Mar 2000) |
| gene flow | The movement of genes from one population to another viainterbreeding. (09 Oct 1997) |
| maximal expiratory flow rate | <chest medicine, physiology> Measurement of rate of airflow during the first liter expired after the first 200 ml have been exhausted during a forced vital capacity determination. Common abbreviations are MEFR, FEF 202-1200, and fef 0.2-1.2. Acronym: MEFR (21 Jun 2000) |
| maximal expiratory flow-volume curve | <chest medicine> Curves depicting maximal expiratory flow in liters/second at each point of lung inflation (expressed in liters or percentage of forced vital capacity) during a forced vital capacity determination. Common abbreviation is mefv. (12 Dec 1998) |
| maximal midexpiratory flow rate | Measurement of rate of airflow over the middle half of a forced vital capacity determination (from the 25 percent level to the 75 percent level). Common abbreviations are mmfr and fef 25%-75%. (12 Dec 1998) |
| renal plasma flow | <physiology> The amount of plasma that perfuses the kidneys per unit time, approximately 10% greater than effective renal plasma flow. It should be differentiated from the renal blood flow which refers to the total volume of blood flowing through the renal vasculature, while the renal plasma flow refers to the rate of plasma flow. (12 Dec 1998) |
| peak expiratory flow | The maximum flow at the outset of forced expiration, which is reduced in proportion to the severity of airway obstruction, as in asthma. (05 Mar 2000) |
| peak expiratory flow rate | Measurement of the maximum rate of airflow attained during a forced vital capacity determination. Common abbreviations are pefr and pfr. (12 Dec 1998) |
| peak flow | <chest medicine, physiology> The maximum flow rate of air breathed out during forced expiration. (15 Nov 1997) |
| peak flow rate | Maximum urinary flow rate during voiding as measured by a uroflowmeter. (05 Mar 2000) |
| voiding flow rate | Urinary flow as a function of time during micturition, as graphically recorded by a flow meter. (05 Mar 2000) |
| coronary blood flow |
The amount of blood flowing to the coronary arteries. This may be measured by one of several techniques including indicator dilution or use of radioisotopes.
Ãâó:
|
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|